A randomised clinical trial of two types of chronic indwelling venous access devices used for the for the delivery of chemotherapy to patients with non-haematological malignancy - peripherally inserted central venous catheter (PICC) versus subcutaneoulsy implanted port catheters (PORT)
Completed
- Conditions
- Non haematalogic patients requiring chronic indwelling venous access device for chemotherapyOther -on haematalogic patients requiring chronic indwelling venous access device for chemotherapy
- Registration Number
- ACTRN12606000165583
- Lead Sponsor
- Flinders Medical Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
1.All patients with cancer (excluding leukaemia and myeloma) who require chemotherapy administration through a CVC2.Minimum anticipated duration of CVC directed therapy is 1 month (30 days).3. Patients should have a projected life expectancy of at least 3 months5.Written informed consent.
Exclusion Criteria
1.Inability to provide informed consent2.Any contraindication to insertion of either PICC or PORT catheter3.Anticipated inability to follow-up patient for CVC care4.Previous participation in this trial (ie the same patient cannot be entered twice into the trial in the event that the original CVC is removed and another CVC is to be inserted).5.Patient to receive high dose chemotherapy and stem cell or bone marrow transplantation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method